362 - READ WITH THE EXPERTS: A MULTI-MODALITY IMAGING APPROACH TO DIAGNOSING AND MANAGING HYPERTROPHIC CARDIOMYOPATHY

Co-Chair(s)

• 

  Gillian Nesbitt, FRCPC FACC FASE

  Associate Professor
  CSE
  University of Toronto
• 

  Kevin Ong, MD, FRCPC

  Cardiologist
  Division of Cardiology, University of British Columbia
  St. Paul's Hospital, University of British Columbia

Panelist(s)

• 

  Kibar Yared, MD PhD

  Director, Cardio-Oncology at Scarborough Health Network
  CCON, CSE
  University of Toronto Medical School

Presenter(s)

• MC

  Michael Chetrit, MD

  Cardiologist
  McGill University Health Centre Research Institute
  McGill University
• ED

  Edgar Da Silva, MD

  Clinical fellow
• HN

  Hanh Nguyen, MD, FRCPC

  University of Ottawa Heart Institute
• 

  Darwin Yeung, MD, MPH, FRCPC, FASE (he/him/his)

  Cardiologist
  University of British Columbia
  University of British Columbia
• 

  Anna Woo, MD, SM

  Cardiologist, University health Network

Early Career(s)

• 

  Aws Almufleh, MBBS, MPH, FASE, FHFSA

  Doctor
  CHFS and CSE
  Queen's University
• 

  Sanela Music, MD, FRCPC

  Assistant Professor
  University of Ottawa Heart Institute
  University of Ottawa Heart Institute
• HN

  Hanh Nguyen, MD, FRCPC

  University of Ottawa Heart Institute
• 

  Darwin Yeung, MD, MPH, FRCPC, FASE (he/him/his)

  Cardiologist
  University of British Columbia
  University of British Columbia

Trainee(s)

• ED

  Edgar Da Silva, MD

  Clinical fellow

Moderator(s)

• 

  Annabel Chen-Tournoux, MD

  Associate Professor
  McGill University
  McGill University
• 

  Sanela Music, MD, FRCPC

  Assistant Professor
  University of Ottawa Heart Institute
  University of Ottawa Heart Institute

Planning Committee Member(s)

• 

  Aws Almufleh, MBBS, MPH, FASE, FHFSA

  Doctor
  CHFS and CSE
  Queen's University
• 

  Annabel Chen-Tournoux, MD

  Associate Professor
  McGill University
  McGill University
• MC

  Michael Chetrit, MD

  Cardiologist
  McGill University Health Centre Research Institute
  McGill University
• 

  Robin Ducas, MD, FRCPC, DRCPSC

  Dr.
  University of Manitoba
  University of Manitoba
• 

  Sanela Music, MD, FRCPC

  Assistant Professor
  University of Ottawa Heart Institute
  University of Ottawa Heart Institute
• 

  Kibar Yared, MD PhD

  Director, Cardio-Oncology at Scarborough Health Network
  CCON, CSE
  University of Toronto Medical School

Workshop Description: Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease, with an estimated prevalence of 1 in 500. It represents a significant cause of morbidity and mortality and has garnered considerable attention in the field of cardiology. There have been significant advances in our understanding of HCM's pathophysiology, epidemiology, and patient management, especially with the introduction of cardiac myosin inhibitors, underscoring the importance of recognizing the diagnosis. Recent guidelines on this topic have been updated (2024 CCS CPU, 2024 AHA/ACC, 2023 ESC), all emphasize the importance of a multimodal imaging approach to HCM. Imaging is crucial in the diagnosis of HCM, identification of obstruction, risk stratification, treatment selection, and long-term follow-up of patients.

This expert-led session will offer a comprehensive and interactive approach to imaging assessment in hypertrophic cardiomyopathy. Using a case-based, “read with the experts” format, specialists will guide attendees through the key imaging modalities, echocardiography and MRI, highlighting their roles in diagnosis, prognostication, treatment planning, and follow-up. This workshop will emphasize real-world applications, enabling participants to analyze imaging studies and engage in discussions about clinical decision-making for patients with HCM.